NYSE · OWL
Blue Owl Capital Inc.
$10.41+$0.74 (+7.65%)
Blue Owl Capital Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.76% below the high.
Loading market information…
NASDAQ · ARCC · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Ares Capital Corporation’s quoted price sits in the lower half of its reported 52-week range, 9.56% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Ares Capital Corporation’s forward annual dividend is $1.92 per share, paid quarterly. The forward yield is 10.04% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Ares Capital Corporation’s next earnings report is currently expected on Feb 3, 2027, with estimated earnings per share of $0.49. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Ares Capital Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Ares Capital Corporation (ARCC) operates as a Business Development Company (BDC), delivering diverse financing solutions predominantly to middle-market enterprises. The firm's expertise lies in facilitating various corporate actions, including funding acquisitions, recapitalizations, and leveraged buyouts. It also extends mezzanine debt, assists with corporate restructurings, and provides crucial rescue financing, in addition to offering growth capital and general refinancing options. ARCC primarily targets investments in companies within the basic and growth manufacturing, business services, consumer products, healthcare (both products and services), and information technology service sectors. Opportunistically, it also explores prospects in industries such as restaurants, retail, oil and gas, and the broader technology space. Geographically, ARCC maintains a broad reach across the United States. Its New York office oversees investments in the Northeast, Mid-Atlantic, Southeast, and Southwest regions. The Chicago office manages opportunities in the Midwest, while its Los Angeles presence covers the Western region. In terms of deal parameters, ARCC typically commits between $20 million and $200 million per investment, with an upper limit of $400 million, targeting companies that generate an EBITDA of $10 million to $250 million. For debt-specific placements, the investment range is generally $10 million to $100 million. The company employs a wide array of financial instruments, including revolving credit facilities, first and second lien loans, unitranche structures, warrants, mezzanine debt, private high yield, junior capital, and subordinated debt, alongside selective non-control preferred and common equity investments. ARCC also evaluates participation in senior and subordinated debt financings led by other parties and strategically acquires stressed or discounted debt. It frequently assumes a lead or agent role in its transactions and actively seeks board representation in its portfolio companies.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:53 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 | Jul 29, 2025 | $0.50-1.19% vs estimate | $579.00M-22.68% vs estimate |
|---|
| Q1 2025 | Apr 29, 2025 | $0.50-5.66% vs estimate | $446.00M-41.59% vs estimate |
|---|
| Q4 2024 | Feb 5, 2025 | $0.55-5.17% vs estimate | $759.00M-3.36% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
32 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 1 contributors · Median target $19.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.41+$0.74 (+7.65%)
Blue Owl Capital Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.76% below the high.
$55.90+$1.29 (+2.36%)
Main Street Capital Corporation’s quoted price sits in the lower half of its reported 52-week range, 14.3% below the high.
$17.62+$0.30 (+1.73%)
Sixth Street Specialty Lending, Inc.’s quoted price sits in the lower half of its reported 52-week range, 23.06% below the high.
$23.41+$0.40 (+1.74%)
Capital Southwest Corporation’s quoted price sits in the upper half of its reported 52-week range, 9.09% below the high.
$12.13+$0.33 (+2.8%)
Oaktree Specialty Lending Corporation’s quoted price sits in the lower half of its reported 52-week range, 13.67% below the high.
$9.06+$0.20 (+2.26%)
Goldman Sachs BDC, Inc.’s quoted price sits in the lower half of its reported 52-week range, 12.72% below the high.
$1.62+$0.10 (+6.58%)
Prospect Capital Corporation’s quoted price sits in the lower half of its reported 52-week range, 48.24% below the high.
$10.40+$0.16 (+1.56%)
MidCap Financial Investment Corporation’s quoted price sits in the upper half of its reported 52-week range, 15.72% below the high.
